Welch V - Search Results

1

Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.

Welch V, Petticrew M, Petkovic J, Moher D, Waters E, White H, Tugwell P; PRISMA-Equity Bellagio group. Welch V, et al. Int J Equity Health. 2015 Oct 8;14:92. doi: 10.1186/s12939-015-0219-2. Int J Equity Health. 2015. PMID: 26450828 Free PMC article. Review.

2

Responsiveness of endpoints in osteoporosis clinical trials--an update.

Cranney A, Welch V, Tugwell P, Wells G, Adachi JD, McGowan J, Shea B. Cranney A, et al. Among authors: welch v. J Rheumatol. 1999 Jan;26(1):222-8. J Rheumatol. 1999. PMID: 9918268 Review.

3

Cyclosporine for rheumatoid arthritis.

Wells G, Haguenauer D, Shea B, Suarez-Almazor ME, Welch VA, Tugwell P. Wells G, et al. Among authors: welch va. Cochrane Database Syst Rev. 2000;1998(2):CD001083. doi: 10.1002/14651858.CD001083. Cochrane Database Syst Rev. 2000. PMID: 10796412 Free PMC article. Review.

4

Low level laser therapy (classes I, II and III) for the treatment of osteoarthritis.

Brosseau L, Welch V, Wells G, deBie R, Gam A, Harman K, Morin M, Shea B, Tugwell P. Brosseau L, et al. Among authors: welch v. Cochrane Database Syst Rev. 2000;(2):CD002046. doi: 10.1002/14651858.CD002046. Cochrane Database Syst Rev. 2000. PMID: 10796460 Updated. Review.

5

Low level laser therapy (classes I, II and III) in the treatment of rheumatoid arthritis.

Brosseau L, Welch V, Wells G, deBie R, Gam A, Harman K, Morin M, Shea B, Tugwell P. Brosseau L, et al. Among authors: welch v. Cochrane Database Syst Rev. 2000;(2):CD002049. doi: 10.1002/14651858.CD002049. Cochrane Database Syst Rev. 2000. PMID: 10796462 Updated. Review.

6

Low level laser therapy for osteoarthritis and rheumatoid arthritis: a metaanalysis.

Brosseau L, Welch V, Wells G, Tugwell P, de Bie R, Gam A, Harman K, Shea B, Morin M. Brosseau L, et al. Among authors: welch v. J Rheumatol. 2000 Aug;27(8):1961-9. J Rheumatol. 2000. PMID: 10955339

7

The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.

Rostom A, Wells G, Tugwell P, Welch V, Dubé C, McGowan J. Rostom A, et al. Among authors: welch v. J Rheumatol. 2000 Sep;27(9):2203-14. J Rheumatol. 2000. PMID: 10990235

8

Transcutaneous electrical nerve stimulation for knee osteoarthritis.

Osiri M, Welch V, Brosseau L, Shea B, McGowan J, Tugwell P, Wells G. Osiri M, et al. Among authors: welch v. Cochrane Database Syst Rev. 2000;(4):CD002823. doi: 10.1002/14651858.CD002823. Cochrane Database Syst Rev. 2000. PMID: 11034768 Updated. Review.

9

Efficacy and toxicity of old and new disease modifying antirheumatic drugs.

Tugwell P, Welch V, Suarez-Almazor M, Shea B, Wells G. Tugwell P, et al. Among authors: welch v. Ann Rheum Dis. 2000 Nov;59 Suppl 1(Suppl 1):i32-5. doi: 10.1136/ard.59.suppl_1.i32. Ann Rheum Dis. 2000. PMID: 11053083 Free PMC article. Review. No abstract available.

10

A review of economic evaluation in osteoporosis.

Cranney A, Coyle D, Welch V, Lee KM, Tugwell P. Cranney A, et al. Among authors: welch v. Arthritis Care Res. 1999 Dec;12(6):425-34. doi: 10.1002/1529-0131(199912)12:6<425::aid-art11>3.0.co;2-a. Arthritis Care Res. 1999. PMID: 11081014 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

406 results

Search Page